Inserter and methods of use

• US 20070027381A1
• Filed: 07/29/2005
• Published: 02/01/2007
• Est. Priority Date: 07/29/2005
• Status: Abandoned Application

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Therasense Incorporated (Abbott Laboratories)
• Inventors: Stafford, Gary
• Application Number:
  US11/192,773
• Publication Number:
  US 20070027381A1
• Time in Patent Office: Days
• US Class Current: 600/347
• CPC Class Codes: A61B 2560/063 Devices specially adapted for delivering implantable medical measuring apparatus
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors

Abstract

Method and apparatus for providing a housing integrated with a sensor introducer and a sensor in analyte monitoring system to deploy the sensor and retain the introducer within the housing upon sensor deployment, and mounting a transmitter to the housing to receive the sensor data is described. The housing may be placed on the skin of a patient and a spring biased mechanism, separately provided and coupled to the introducer or by integrally configuring the introducer, triggers the introducer to deploy the insertion mechanism for placement of the sensor at a predetermined depth under the skin of the patient.

Claims

1. An apparatus including an inserter, comprising:

a housing for placement on a patient, the housing comprising a cavity;

an introducer positioned at least substantially in the cavity, the introducer configured for displacement substantially within the cavity of the housing; and

a sensor coupled to the introducer and at least partially positioned in the cavity for transcutaneous deployment in the patient;

wherein at least a portion of the sensor and the introducer are retained within the cavity of the housing after deployment of the sensor in the patient.

2. The apparatus of claim 1 wherein the sensor is an electrochemical sensor.

3. The apparatus of claim 1 further including a transmitter unit mountable to the housing, and further, wherein the transmitter unit is configured to be in electrical contact with the sensor.

4. The apparatus of claim 3 wherein the transmitter unit is configured to receive a signal corresponding to an analyte level detected by the sensor, and further, to transmit the signal.

5. The apparatus of claim 4 wherein the transmitter unit includes a wireless communication unit for wireless transmission of the signal.

6. The apparatus of claim 5 wherein the wireless communication unit includes one or more of an rf communication unit, a Bluetooth communication unit, an infrared communication unit, an 801.11x communication unit, or a Zigbee communication unit.

7. The apparatus of claim 1 wherein the introducer is configured with a spring mechanism such that the displacement force of the introducer substantially corresponds to the spring mechanism.

8. The apparatus of claim 7 wherein the spring mechanism includes a torsion coil coupled to the introducer within the housing.

9. The apparatus of claim 7 wherein the introducer is substantially flexible and is provided with the spring mechanism.

10. The apparatus of claim 9 further including a plunger coupled to the introducer to trigger the spring mechanism of the introducer.

11. The apparatus of claim 1 wherein a portion of the sensor is fixedly positioned within the cavity upon deployment of the sensor by the introducer.

12. The apparatus of claim 1 wherein the introducer is substantially completely positioned within the cavity of the housing after the deployment of the sensor.

13. The apparatus of claim 1 wherein the sensor is a glucose sensor.

14. A method of introducing a sensor, comprising:

placing a housing on a skin of a patient, the housing including a sensor and a sensor introducer, the housing further configured to removably couple to a transmitter;

activating an insertion mechanism coupled to the housing to insert the sensor through the skin of the patient; and

retaining at least a portion of the sensor and the insertion mechanism within the housing after activating the insertion mechanism.

15. The method of claim 14 wherein the transmitter is in electrical contact with the sensor.

16. The method of claim 15 further including the step of detecting an analyte level of the patient by the sensor, and providing the detected analyte level to the transmitter for signal transmission.

17. The method of claim 16 wherein the signal transmission includes wireless transmission of a signal corresponding to the analyte level.

18. The method of claim 14 wherein the sensor is a glucose sensor.

19. An insertion kit, comprising:

a housing for transcutaneously inserting an analyte sensor and monitoring an analyte level of a patient, the housing having a cavity and the analyte sensor therein, the housing for placement on the patient; and

an introducer positioned at least substantially in the cavity and coupled to the analyte sensor, the introducer configured to insert the analyte sensor through a skin of the patient to a predetermined depth;

wherein at least a portion of the analyte sensor and the introducer are retained within the cavity of the housing after deployment of the sensor in the patient.

20. The kit of claim 19 wherein the inserted analyte sensor is in fluid contact with the analyte of the patient.